Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
14.84
-0.05 (-0.34%)
Nov 20, 2026, 11:34 AM EST - Market open
Aurinia Pharmaceuticals Market Cap
Aurinia Pharmaceuticals has a market cap or net worth of $1.99 billion as of November 20, 2026. It is the 6,303rd most valuable company in the world and the 1,714th biggest in the United States. Its market cap has decreased by 0.77% in one year.
Market Cap
1.99B
Enterprise Value
1.56B
1-Year Change
-0.77%
Global Rank
Country Rank
#1,714 United States
Category
ChartMarket Cap Chart
Since September 3, 2014, Aurinia Pharmaceuticals's market cap has increased from $125.50M to $1.99B, an increase of 1,484.49%. That is a compound annual growth rate of 25.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.99B | -5.44% |
| Dec 31, 2025 | 2.10B | 63.56% |
| Dec 31, 2024 | 1.29B | -0.41% |
| Dec 29, 2023 | 1.29B | 110.29% |
| Dec 30, 2022 | 613.90M | -79.30% |
| Dec 31, 2021 | 2.97B | 69.58% |
| Dec 31, 2020 | 1.75B | -8.45% |
| Dec 31, 2019 | 1.91B | 233.25% |
| Dec 31, 2018 | 573.20M | 50.68% |
| Dec 29, 2017 | 380.40M | 366.75% |
| Dec 30, 2016 | 81.50M | 3.69% |
| Dec 31, 2015 | 78.60M | -31.17% |
| Dec 31, 2014 | 114.20M | -9.00% |
| Sep 3, 2014 | 125.50M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lakefront Biotherapeutics NV | 2.22B |
| Celldex Therapeutics | 2.20B |
| Palvella Therapeutics | 2.11B |
| Beam Therapeutics | 2.06B |
| Immunome | 2.03B |
| Biohaven | 2.00B |
| Harmony Biosciences Holdings | 1.94B |
| Trevi Therapeutics | 1.93B |